Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 13

Depression and Anxiety in Patients with Bullous Pemphigoid: Impact and Management Challenges

Authors Kluger N, Pankakoski A, Panelius J

Received 26 November 2019

Accepted for publication 3 January 2020

Published 21 January 2020 Volume 2020:13 Pages 73—76


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jeffrey Weinberg

Nicolas Kluger, Anna Pankakoski, Jaana Panelius

Department of Dermatology, Allergology and Venereology, Helsinki University Hospital, Helsinki, Finland

Correspondence: Nicolas Kluger
Department of Dermatology, Skin and Allergies Hospital, Meilahdentie 2, PO Box 160, Helsinki 00029 HUS, Finland

Abstract: Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. It is also associated with high mortality and poor prognosis due to advanced age of the patients and coexisting comorbidities. There is a dearth of data in the literature regarding depression and anxiety among those patients. The objective of this brief review is to discuss the intertwining relationship between depression and anxiety with bullous pemphigoid.

Keywords: anxiety, bullous pemphigoid, corticosteroids, depression, drug-induced bullous pemphigoid, quality of life

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]